Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 1,943 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Pediatric Asthma
Interventions: CASE in person version (High Intensity Package), CASE-V remote version (Low Intensity Package), CASE and HARP in person (High Intensity package), CASE-V and HARP-V remote version (Low Intensity package); Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 2 Years to 12 Years
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Solid Tumor, Adult
Interventions: HMPL-A830; Drug
Lead sponsor: Hutchmed; Industry
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 6
States / cities: Orange, California • Coral Springs, Florida • Plantation, Florida + 3 more

Conditions: Prostate Cancer
Interventions: PGV-001, Poly-ICLC, CDX-301; Biological
Lead sponsor: Ashutosh Kumar Tewari; Other
Eligibility: 18 Years and older · Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Adult Influenza Vaccinations, Adult PPSV Vaccinations, Adult Tdap/Td Vaccinations
Interventions: Pillar 1: Convenient Vaccination Services, Pillar 2: Patient notification, Pillar 3: Enhanced Office Systems, Pillar 4: Motivation; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 70,549 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Houston, Texas

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Disease
Interventions: Institutional standard of care, Biosamples of airway and blood; Other
Lead sponsor: Boston University; Other
Eligibility: 46 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 19
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 13 more

Conditions: Behavior, Health, Child Obesity
Interventions: Greenlight Plus, Greenlight; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Up to 21 Days
Enrollment: 900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 6
States / cities: Stanford, California • Coral Gables, Florida • New York, New York + 3 more

Conditions: Kidney Failure, Chronic, End-Stage Renal Disease
Interventions: NxStage System One; Device
Lead sponsor: NxStage Medical; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 9
States / cities: San Jose, California • Chicago, Illinois • Indianapolis, Indiana + 6 more

Conditions: Prehypertension, Hypertension, Blood Pressure
Interventions: Health Education, Individual-Level Peer Support, Community-Level Peer Support; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 416 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: End Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Kidney Disease
Interventions: Moda-flx Hemodialysis System; Device
Lead sponsor: Diality Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Ontario, California

Conditions: Type 2 Diabetes, Glycemic Control, Cardiovascular Risk Factors, Psychological Distress
Interventions: Special Intervention; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Migraine, Depression
Interventions: ACT-ME, Migraine Education Only; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Prostatic Neoplasms
Interventions: G-202; Drug
Lead sponsor: GenSpera, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Smoking Cessation
Interventions: Smiling instead of Smoking - HIV, QuitGuide; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognition, Obese Older Adults, Mediterranean Diet
Interventions: MedDiet; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 55 Years to 85 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Refractory Viral Infections
Interventions: mCTLs; Biological
Lead sponsor: Catherine Bollard; Other
Eligibility: 4 Weeks to 45 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Stroke
Interventions: Transitions of Care Coordinator, Usual Care; Other
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Cancer Metastatic, Symptoms and Signs, Quality of Life
Interventions: Symptom Management and Survivorship Handbook + Coaching, Symptom Management and Survivorship Handbook; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Emotional Disturbances, Depression, Pregnancy Late, Post-Partum Depression, Anxiety, Nutritional Deficiency
Interventions: COPE-P; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 299 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: The Bronx, New York • Columbus, Ohio

Conditions: Atrial Fibrillation, Stroke
Interventions: On-screen electronic alert; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 798 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Overweight, Weight Loss
Interventions: Physician Counseling, Health Educator, Phone Counseling, Health promotion materials on physical activity and nutrition; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 11 Years to 13 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Binge Drinking, Heavy Drinking, Young Adult, Heavy Drinker, Alcohol Drinking, Alcohol Drinking in College, Drinking Behavior, Drunkenness, Drinking Excessive, Drinking Problem, Drink Too Much, College Drinking
Interventions: Regulation of craving, Control (NO REGULATION); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Crohn's Disease
Interventions: Ustekinumab; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 2 Years to 25 Years
Enrollment: 545 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2- Breast Cancer, ESR1 Gene Mutation, ER Wildtype, Breast Neoplasms
Interventions: Capecitabine, Elacestrant; Drug
Lead sponsor: Kristina A. Fanucci; Other
Eligibility: 18 Years and older
Enrollment: 297 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

HMPL-A830 in Solid Tumors

The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.

SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™

Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY

First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings

Latinos Understanding the Need for Adherence in Diabetes

One-Day Intervention for Depression and Impairment in Migraine Patients

G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer

Testing the Integrated mHealth App Intervention "SiS-H"

Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults

Multivirus-specific Cytotoxic T Lymphocytes (mCTL)

Stroke Transitions of Care to Reduce Hospital Length of Stay

Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers

Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women

Electronic Alerts for Stroke Prevention in Atrial Fibrillation

PACE-PC: Primary Care Management of Adolescent Obesity

Brief ROC Training Effects on Alcohol Drinking

A Study of Ustekinumab Treatment in Children With Crohn's Disease

PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)